Overview

A Study to Diagnose Lung Cancer by Sputum Cytology (01-312)

Status:
Completed
Trial end date:
2003-12-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to determine if more diagnoses of lung cancer are obtained from the cytological evaluation of sputum expectorated following a single inhaled dose of UTP compared to sputum expectorated following a single inhaled dose of placebo in patients suspected of having lung cancer.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Pharmaceutical Solutions